ADPT.NASDAQAdaptive Biotechnologies CORP
Form 4: Adaptive Biotechnologies Director Sells 53,000 Shares
Sentiment:
SEC Form 4 Filing
Robert Hershberg, a director at Adaptive Biotechnologies Corp, sold 53,000 shares of common stock on March 12, 2025, at a price of $7.59 per share.
Summary
- On March 12, 2025, Robert Hershberg, a director of Adaptive Biotechnologies Corp, sold 53,000 shares of the company's common stock.
- The sale was executed at a price of $7.59 per share.
- Following the transaction, Hershberg directly owns 69,690 shares of Adaptive Biotechnologies Corp.
Sentiment
Score: 5
Explanation: The document simply reports a stock sale by a director, which is neutral in sentiment.
Stakeholder Impact
- The sale of shares by a director could potentially influence investor sentiment, although the impact is likely to be minimal given the size of the transaction relative to the company's overall market capitalization.
Key Dates
| Date | Description |
|---|---|
| 03/12/2025 | Date of stock sale transaction |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.